www.bcaction.org/Pages/SearchablePages/2000Newsletters/ -
[Cached Version]
Published on: 1/1/2000
Last Visited: 3/19/2007
Edward A. Sickles, a radiology professor and section chief of Breast Imaging at the University of California at San Francisco, offers this clarification."The FDA's role was to approve the Senographe 2000D based on safety and effectiveness rather than on how good the technology could get," he says."In order to get FDA approval, the research and development efforts were aimed at showing that digital mammography is equivalent to, rather than better than, traditional mammography."
What this means is that five to ten years from now, as R&D efforts shift, digital mammography could greatly surpass the systems we have in place today, Sickles says.